Genotyping of 22 human papillomavirus types by DNA chip in Korean women: Comparison with cytologic diagnosis

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 1, 2003, Pages 56-62

  Cho, Nam Hoon ^a   An, Hee Jung ^b   Jeong, Jeongmi Kim ^b   Kang, Suki ^b   Kim, Jae Wook ^b   Kim, Young Tae ^b   Park, Tchan Kyu ^b  

^a Yonsei University College of Medicine   (South Korea)

^b NONE

Author keywords

Coinfection; DNA chip; Genotyping; Human papillomavirus

Indexed keywords

ARTICLE; CANCER CELL CULTURE; DNA MICROARRAY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMA VIRUS 58; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTERMETHOD COMPARISON; KOREA; NONHUMAN; OLIGONUCLEOTIDE PROBE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

EID: 0037250117     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.120     Document Type: Article

References (25)

1. Turek LP, Smith EM. The genetic program of genital human papillomaviruses in infection and cancer. Obstet Gynecol Clin North Am 1996;23:735-58.
2. Campion MJ, Greenberg MD, Kazamel TIG. Clinical manifestations and natural history of genital human papillomavirus infections. Obstet Gynecol Clin North Am 1996;23:783-809.
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective: International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
4. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 1992;89:12180-4.
5. Liaw K, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, et al. A prospective study of human papillomavirus type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001;183:8-15.
6. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001;64:550-9.
7. Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee S, Adam DE, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000;182:1097-102.
8. Matsukura T, Sugase M. Relationship between 80 human papillomavirus genotypes and different grades of cervical intraepithelial neoplasia: association and causality. Virology 2001;283:139-47.
9. McMurray HR, Nguyen D, Westbrook TF, McAnce DJ. Biology of human papillomaviruses. Int J Exp Pathol 2001;82:15-33.
10. Schlegel R, Wade-Glass M, Rabson MS, Yang YC. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science 1986;233:464-7.
11. Burkhardt A, DiMaio D, Schelegel R. Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein. EMBO J 1987;6:2381-5.
12. Leechanachai P, Banks L, Moreau F, Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 1992;7:19-25.
13. DiMaio D. Transforming activity of bovine and human papillomavirus in cultured cells. Adv Cancer Res 1991;56:133-59.
14. Turek LP. The structure, function, and regulation of papillomaviral genes in infection and cervical cancer. Adv Virus Res 1994;44:305-56.
15. Stoler MH. The biology of human papillomaviruses and their role in cervical carcinogenesis. In: Bonfiglio TA, Eroszan YS, editors. Gynecologic cytopathology. Vol 20. Philadelphia: Lippincott-Raven; 1997. p. 51-72.
16. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF, et al. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988;159:293-6.
17. Meyer T, Arndt R, Christophers E, Beckmann E, Schroder S, Gissmann L, et al. Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis 1998;178:252-5.
18. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
19. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-7.
20. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologue lesions. Int J Cancer 1995;61:13-22
21. Nuovo GJ, Darfler MM, Impraim CC, Bromley SE. Occurrence of multiple types of human papillomavirus in genital tract lesions. Am J Pathol 1991;138:53-8.
22. Myeres G, Lu H, Calef C, Leitner T. Heterogeneity of papillomaviruses. Semin Cancer Biol 1996;7:349-58.
23. Roden RB, Greenstone HL, Kirnbauer R, Booy FP, Jessie J, Lowy DR, et al. In vitro generation and type specific neutralization of a human papillomavirus type 16 virion pseudotype. J Virol 1996;70:5875-83.
24. Wallin K, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al. Type-specific persistence of human papillomavirus and before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8.
25. Van Ballegooijen M, van den Akker-van Marle ME, Warmerdam PG, Meijer CJLM, Wallboomers JMM, Habbema JD. Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost) effectiveness. Br J Cancer 1997;76:651-7.